Abstract

One of the most important scientific discoveries in the recent past concerns RNA interference (RNAi), which is a post-transcriptional gene-silencing mechanism induced by small interfering RNA (siRNA) and micro-RNA (miRNA).[1] RNAi has opened up new avenues in the development of siRNA and miRNA as therapeutic agents for various diseases.[2] The reason for the large number of reports about chemically modified siRNA is their potential to enhance nuclease resistance, to prevent immune activation, to decrease off-target effects, and to improve pharmacokinetic and pharmacodynamic properties, all of which are important for the application of siRNA as therapeutic agents.[3] Another substantial challenge is siRNA delivery, because these reagents cannot easily traverse cell membranes because of their size and negative charge.[4] To date, the most promising therapeutic approach based on RNAi involves chemically modified siRNA that can resolve some of the issues mentioned above.

Highlights

  • One of the most important scientific discoveries in the recent past concerns RNA interference (RNAi), which is a post-transcriptional gene-silencing mechanism induced by small interfering RNA and micro-RNA.[1]

  • Chemical small interfering RNA (siRNA) modifications belong to four classes—backbone, ribose, nucleobase, and terminal modifications—with ribose modifications being the most common.[2b]. Structurally simple alterations, such as 2’-OCH3 and 2’-F, lead to significantly enhanced performance of siRNA with diverse target genes, provided that they are positioned in a site-specific manner.[3]

  • The guide strand is incorporated into the crucial functional particle, the RNA-induced silencing complex (RISC); RNA recognition and discrimination from non-native counterparts is very stringent.[6]

Read more

Summary

Introduction

One of the most important scientific discoveries in the recent past concerns RNA interference (RNAi), which is a post-transcriptional gene-silencing mechanism induced by small interfering RNA (siRNA) and micro-RNA (miRNA).[1]. It is even more surprising that, to the best of our knowledge, the solid-phase chemical synthesis of 2’-azido-modified RNA has not yet been described.[8] The prospect of potential siRNA applications, and of promising applications in modern bioconjugation chemistry (such as Staudinger ligation and click chemistry)[9] prompted us to take up the challenge of synthesizing these RNA derivatives (Scheme 1).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call